Metraipolis › archive › dc_ffc4ccc17354

Doubly robust estimation of while-alive estimands in individually-randomized and cluster-randomized trials — arXiv:2608.15969

Source
arXiv (en)
Original
https://arxiv.org/abs/2608.15969
License (as archived)
CC0-1.0
Archived
2026-10-18T20:02:04.983Z
SHA-256 of the archived text
e2aa88739fc2438d5dd54a62dfb02d32629c1ed927b0b4f1ddf483c9d574cd70
Stable URL of this page
https://metraipolis.com/documento/dc_ffc4ccc17354

How to cite

Doubly robust estimation of while-alive estimands in individually-randomized and cluster-randomized trials — arXiv:2608.15969 — arXiv (en), https://arxiv.org/abs/2608.15969 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ffc4ccc17354 (Metraipolis archive dc_ffc4ccc17354, sha256 e2aa88739fc2438d5dd54a62dfb02d32629c1ed927b0b4f1ddf483c9d574cd70)
BibTeX
@misc{dcffc4ccc17354,
  title = {Doubly robust estimation of while-alive estimands in individually-randomized and cluster-randomized trials — arXiv:2608.15969},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2608.15969},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ffc4ccc17354; sha256 e2aa88739fc2438d5dd54a62dfb02d32629c1ed927b0b4f1ddf483c9d574cd70},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2608.15969. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Randomized trials in chronic disease settings often measure treatment benefit through recurrent non-fatal events that are truncated by death, where conventional summaries either discard recurrences, conflate the treatment effect with survival, or treat death as censoring and forfeit a causal interpretation. While-alive estimands measure event burden per unit time alive, but doubly robust estimation for the exposure-weighted while-alive rate remains undeveloped, particularly in cluster-randomized trials (CRTs). We develop a doubly robust estimator based on a local Nelson-Aalen representation, with augmented estimating equations targeting the marginal hazard of the terminal event and the weighted recurrent event rate among those alive; the estimator accommodates multiple event types through prespecified clinical weights and remains consistent if either the censoring model or the outcome working models are correctly specified. For CRTs, we define a new pair of individual-average and cluster-average estimands under informative cluster size, with inference based on cluster-level influence functions. We establish component-wise double robustness and asymptotic normality, corroborate the theory in simulations, and illustrate the methods with reanalyses of data from two completed randomized trials.

Tema degli esploratori: statistica e scienza dei dati (retro-catalogo arXiv: annunci del 2026-08-18 in stat.ME).
Categorie arXiv: Methodology (stat.ME).
Pagina del lavoro: https://arxiv.org/abs/2608.15969 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-18T19:44:19.567Z dalla pagina https://arxiv.org/catchup/stat.ME/2026-08-18?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).